Skip to main content
. 2014 Jul 9;4(7):140067. doi: 10.1098/rsob.140067

Figure 4.

Figure 4.

Kaplan–Meier survival curves comparing months of survival in GC patients are shown for (a) methylated CpG site count of BCL6B promoter, (b) methylated status of CpG +79 of BCL6B promoter, (c) tumour size, (d) depth of tumour invasion (T stage), (e) number of metastatic lymph nodes and (f) location of lymph node metastasis.